The bioinformatics industry in Latin America is rapidly evolving, focusing on the intersection of biology and technology. Companies in this field are working on areas like genomics, drug discovery, and health data analytics. With research institutions and innovative startups emerging across the region, there's a growing push toward personalized medicine and advanced biotech solutions. Noteworthy trends include partnerships between academia and private entities, driving forward research and commercialization efforts. This vibrant sector is expected to thrive as more investors recognize its potential, paving the way for groundbreaking discoveries that enhance healthcare outcomes.


Investors in the Latin American bioinformatics space showcase varied profiles, including venture capital firms, corporate investors, and incubators. Many are headquartered in major cities like Sao Paulo and Santiago, with a mix of newly founded firms and established players from the 2000s. In 2024, these investors collectively engaged in numerous funding rounds, reflecting a healthy appetite for deals. Their portfolio sizes range from small emerging teams to sizeable firms, signaling a strategic focus on innovative biotech and health solutions, evidenced by their deal counts across promising startups and initiatives.


Top 18 Bioinformatics Investors in Latin America


1. bossa invest

  • Website: bossainvest.com
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2011
  • Headcount: 11-50
  • Number of deals in 2024: 56
  • LinkedIn: bossainvest

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in the technology sector, and provides capital, strategic guidance, and access to a network of co-investors. Bossa Invest has been active in the bioinformatics space, having participated in funding rounds for companies like Nuanced Health, which focuses on health technology, and Caribou Biosciences, known for its CRISPR technology platform. In 2021, Bossa Invest was involved in funding rounds for Nuanced Health and Caribou Biosciences, indicating their commitment to supporting advancements in the bioinformatics and biotechnology sectors. Additionally, Bossa Invest offers educational resources for investors and startups, aiming to empower entrepreneurs and foster growth in the startup ecosystem.


2. Eretz.bio

  • Website: eretz.bio
  • Type: Corporate
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2017
  • Headcount: 11-50
  • Number of deals in 2024: 16
  • LinkedIn: eretz.bio

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with the Hospital Israelita Albert Einstein, focusing on incubating startups in the healthcare sector, particularly in biotechnology, digital health, and medical devices. Eretz.bio has been involved in several seed and venture funding rounds, including investments in Neoprospecta, BiomeHub, and RioGen, which are relevant to the bioinformatics field. These transactions highlight Eretz.bio's commitment to supporting innovative solutions that may leverage bioinformatics technologies, thereby enhancing its profile as a bioinformatics investor.


3. GRIDS Capital

  • Website: gridscapital.com
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2016
  • Headcount: 1-10
  • Number of deals in 2024: 1
  • LinkedIn: grids-capital

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures and provides investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, they participated in significant funding rounds for companies such as BigHat Biosciences, which focuses on AI/ML-wet lab platforms for biotechnology, and Hedera Dx, a techbio company developing blood-based testing solutions for cancer DNA profiling. These investments demonstrate GRIDS Capital's active role in advancing bioinformatics and related technologies.


4. The Ganesha Lab

  • Website: theganeshalab.com
  • Type: Corporate
  • Headquarters: Las Condes, Santiago, Chile
  • Founded year: 2016
  • Headcount: 1-10
  • Number of deals in 2024: 5
  • LinkedIn: ganeshalab

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It supports early-stage biotech startups in Latin America through various programs, including BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate the complexities of the biotech industry and scale their innovations for global impact. Notable transactions include investments in metaBIX Biotech and Smart Tissues, both of which are in the early stages of development and may have bioinformatics applications. Additionally, they have provided non-equity assistance to companies like Nanotransfer and Amplify Dynamics, further demonstrating their active role in supporting biotech ventures.


5. AIR Capital

  • Website: aircapital.vc
  • Type: Corporate
  • Headquarters: Buenos Aires, Buenos Aires, Argentina
  • Founded year: 2021
  • Headcount: 1-10
  • Number of deals in 2024: 13
  • LinkedIn: air-capital-vc

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm specializes in investing in early-stage startups that focus on disruptive innovations relevant for humanity. AIR Capital supports entrepreneurs by providing both investment and consulting services, leveraging insights from their extensive experience in the technology sector. Their portfolio includes a diverse range of startups across various industries, with a notable emphasis on biotechnology and health-related sectors. Among their relevant transactions, AIR Capital has invested in Aplife Biotech, which raised funds in 2022, and Oncoliq, which secured funding in 2024. These investments highlight their commitment to fostering innovation in areas that intersect with bioinformatics, making them a significant player in this field.


6. SP Ventures

  • Website: spventures.com.br
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2007
  • Headcount: 1-10
  • Number of deals in 2024: 3
  • LinkedIn: sp-ventures

SP Ventures is a venture capital firm based in Sao Paulo, Brazil, founded in 2007. The firm specializes in investments in technology-driven solutions for the agriculture and food sectors, particularly in Latin America. They support early-stage startups by providing capital and consulting services to help them innovate and grow. Notably, SP Ventures has been involved in several transactions relevant to the bioinformatics context, including investments in Gênica, which raised $5.7 million in 2022 and $1.6 million in 2017, focusing on genetic technologies. Additionally, their investment in Genotyping, which raised over $1 million in 2015, further emphasizes their engagement in the biotechnology space. Their support for Decoy Smart Control, which is developing biological controls for animal agriculture, also highlights their interest in innovative agricultural solutions that may utilize bioinformatics. Overall, SP Ventures is positioned as a key player in the AgFood value chain, with a portfolio that includes companies leveraging biotechnology and bioinformatics.


7. Cites

  • Website: cites-gss.com
  • Type: Venture Capital
  • Headquarters: Sunchales, Santa Fe, Argentina
  • Founded year: 2014
  • Headcount: 51-200
  • Number of deals in 2024: 2
  • LinkedIn: cites

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm focuses on supporting the development of scientific and technological startups by providing venture capital investment, mentorship, and access to resources. Cites primarily targets early-stage startups looking to transform innovative ideas into successful businesses. Notably, Cites has invested in several companies relevant to the bioinformatics sector, including Limay Biosciences, which raised $600,000 in a seed round in August 2022, and Ergo Bioscience, which raised $1,602,220 in September 2023. Other investments include Phylumtech, RadBio, and ARDAN PHARMA, all of which are involved in biotechnology and related fields, further emphasizing Cites' commitment to fostering innovation in bioinformatics and life sciences.


8. IKJ Capital

  • Website: ikj.capital
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2019
  • Headcount: 1-10
  • Number of deals in 2024: 7
  • LinkedIn: irukandji-capital

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investing in early-stage healthcare technology companies, aiming to tackle significant healthcare challenges such as mental health and chronic conditions. In 2024, IKJ Capital has been actively involved in several funding rounds, including notable investments in Shift Bioscience, which raised over $16 million in a seed round, indicating a strong interest in innovative solutions that may intersect with bioinformatics. They also invested in Portal, which raised a total of $12 million across two rounds, and Earli, which is involved in healthcare technology. These transactions highlight IKJ Capital's commitment to supporting startups that are likely to contribute to advancements in healthcare, including bioinformatics.


9. Zentynel Frontier Investments


Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to high-growth potential companies in the sector. In 2023, Zentynel led a seed funding round for MultiplAI Health, a diagnostics company focused on technical validation and expansion in the US market. Additionally, they participated in a Series A-1 financing round for Autem Therapeutics, which is developing a novel bioelectric oncology treatment platform targeting solid tumor cancers. Their recent investments also include BIOMAKERS and Xeptiva Therapeutics, further demonstrating their active role in supporting innovative biotechnology startups. Through these transactions, Zentynel is helping to navigate the challenges of funding and market entry in the biotechnology and bioinformatics sectors.


10. DNA Capital

  • Website: dnacapital.com
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2013
  • Headcount: 11-50
  • Number of deals in 2024: 1
  • LinkedIn: dna-capital-br

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support aimed at fostering growth and innovation in the healthcare sector. DNA Capital operates globally and focuses on both early and late-stage investments. Among its notable transactions, DNA Capital invested in Cambridge Epigenetix, which raised $30 million in a Series C round in September 2018. This company is known for its work in epigenetics, a field that is closely related to bioinformatics. Additionally, they invested in Spotlight Therapeutics, which raised $30 million in a Series A round in November 2020, further indicating their commitment to innovative healthcare solutions. These investments highlight DNA Capital's engagement in sectors that intersect with bioinformatics, making them a relevant player in this space.


11. Kptl

  • Website: kptl.com.br
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2020
  • Headcount: 11-50
  • Number of deals in 2024: 5
  • LinkedIn: inseed-investimentos

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in the investment landscape, KPTL has made more than 124 investments, focusing on innovative startups across various industries. Among their notable transactions in the biotechnology sector are investments in Celer Biotecnologia, which raised $857,480 in a Series A round in 2008, and Vida Biotecnologia, which secured funding in 2012. More recently, they invested in Omics Animal Biotechnology in 2023, highlighting their ongoing commitment to the biotechnology and bioinformatics fields. KPTL provides not only capital but also strategic guidance to help these companies grow and succeed in their respective markets.


12. Clave Capital

  • Website: clavecapital.com.br
  • Type: Venture Capital
  • Headquarters: Jardim Paulista, Sao Paulo, Brazil
  • Founded year: 2021
  • Headcount: 11-50
  • Number of deals in 2024: 1
  • LinkedIn: clavecapital

Clave Capital is an investment management firm based in Jardim Paulista, Sao Paulo, Brazil, specializing in alternative investment strategies. Founded in 2021, the firm manages various funds focused on equity, credit, and real estate investments. Clave Capital is committed to excellence and disciplined capital allocation, catering to both businesses and individual investors seeking effective asset management and financial growth. Notably, Clave Capital has participated in significant funding rounds in the bioinformatics and healthcare sectors, including a €5.4 million funding round for ADmit Therapeutics, aimed at advancing Alzheimer's disease diagnostics and treatment. Additionally, they led a funding round for MiMARK Diagnostics, which is developing in vitro diagnostic assays for endometrial cancer, further emphasizing their engagement in the biohealth and bioinformatics industries. Their involvement in these transactions highlights their interest in innovative healthcare solutions and positions them as a relevant player in the bioinformatics investment landscape.


13. big_bets

  • Website: bigbets.com.br
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2019
  • Headcount: 1-10
  • Number of deals in 2024: 10
  • LinkedIn:

big_bets is an investment and consulting agency based in Sao Paulo, Brazil, founded in 2019. They specialize in partnering with entrepreneurs to support the development of technology startups through investment consulting, mentoring, and strategic guidance. In 2024, big_bets has made 10 investments, demonstrating their active role in the startup ecosystem. Notably, they have participated in funding rounds for bioinformatics-related companies such as Pepper Bio, a drug discovery startup that raised $6.5 million, and Menten AI, which focuses on AI applications in biology. These transactions highlight big_bets' commitment to fostering innovation in the bioinformatics sector while also supporting a diverse range of technology startups.


14. Aurus

  • Website: aurus.cl
  • Type: Venture Capital
  • Headquarters: Lo Barnechea, Santiago, Chile
  • Founded year: 2008
  • Headcount: 11-50
  • Number of deals in 2024: 1
  • LinkedIn: aurus

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm specializes in partnering with entrepreneurs and startups, offering strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Notably, Aurus has been involved in several funding rounds for Andes Biotechnologies, a company that operates in the biotechnology sector. Their investments include a Series A round in 2010, followed by multiple venture rounds and a Series B round in 2014. This consistent support for Andes Biotechnologies highlights Aurus's engagement in the biotech space, which is closely related to bioinformatics.


15. Fen Ventures

  • Website: fenventures.com
  • Type: Venture Capital
  • Headquarters: Las Condes, Santiago, Chile
  • Founded year: 2012
  • Headcount: 1-10
  • Number of deals in 2024: 5
  • LinkedIn: fen-ventures

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in early-stage investments within the Latin American tech sector, providing capital, strategic support, and networking opportunities to entrepreneurs. In 2024, Fen Ventures participated in several notable transactions, including a $2.5 million seed round for Xeptiva Therapeutics, a company focused on therapeutic solutions, and a $2.1 million investment in Bioeutectics, which is involved in developing green solvents. Additionally, they were part of a $6.4 million seed funding round for Michroma, a company that operates in the biotechnology space. These investments highlight Fen Ventures' engagement in sectors that intersect with bioinformatics, showcasing their commitment to fostering innovation in life sciences and technology.


16. Loyall Capital Partners


Loyall Capital Partners, founded in 2009 and based in Sao Paulo, Brazil, is a corporate investor that specializes in digital experience services, including brand identity creation and UI design. The firm primarily serves startups and small businesses, helping them enhance their digital presence and achieve marketing success through tailored solutions. Notably, Loyall Capital Partners has participated in venture funding rounds for companies in the bioinformatics sector, such as Mendelics, which focuses on genetic testing, and BioSolvit, which provides bioinformatics solutions. These transactions highlight their involvement in the bioinformatics field, albeit as part of a broader investment strategy that includes various industries.


17. Lanx Capital Investimentos


Lanx Capital Investimentos is a corporate investment firm based in Sao Paulo, Brazil, founded in 2003. The firm specializes in private equity, venture capital, and real estate, providing investment management services to businesses and high-net-worth individuals. Lanx Capital aims to achieve exceptional returns through disciplined investment strategies. Notably, they participated in a Series A funding round for OccamzRazor, a New York-based company that raised $6.1M to advance its AI-enabled discovery pipeline for preclinical development in Parkinson's disease. This transaction highlights their engagement in the bioinformatics space, showcasing their interest in innovative healthcare solutions.


18. Beagle Ventures


Beagle Ventures is a venture capital firm based in Santiago, Chile, founded in 2016. The firm specializes in supporting entrepreneurs by providing both investment and strategic guidance, particularly focusing on technology-based service companies in Latin America. Beagle Ventures aims to help these companies expand and succeed in competitive markets. Notably, they participated in a seed funding round for Fauna Bio, a biotechnology company that raised $4.1 million to enhance its discovery platform for identifying new therapeutic targets for human diseases. This transaction highlights Beagle Ventures' engagement in the biotechnology and bioinformatics sectors, showcasing their interest in supporting innovative solutions in health and disease treatment.



Bioinformatics Insights: Key Investors in Latin America


InvestorHeadquarterSizeFoundedDeals 2024
bossa investSao Paulo, Sao Paulo, Brazil11-50201156
Eretz.bioSao Paulo, Sao Paulo, Brazil11-50201716
GRIDS CapitalSao Paulo, Sao Paulo, Brazil1-1020161
The Ganesha LabLas Condes, Santiago, Chile1-1020165
AIR CapitalBuenos Aires, Buenos Aires, Argentina1-10202113
SP VenturesSao Paulo, Sao Paulo, Brazil1-1020073
CitesSunchales, Santa Fe, Argentina51-20020142
IKJ CapitalSao Paulo, Sao Paulo, Brazil1-1020197
Zentynel Frontier InvestmentsSantiago, Santiago, Chile1-1020174
DNA CapitalSao Paulo, Sao Paulo, Brazil11-5020131
KptlSao Paulo, Sao Paulo, Brazil11-5020205
Clave CapitalJardim Paulista, Sao Paulo, Brazil11-5020211
big_betsSao Paulo, Sao Paulo, Brazil1-10201910
AurusLo Barnechea, Santiago, Chile11-5020081
Fen VenturesLas Condes, Santiago, Chile1-1020125
Loyall Capital PartnersSao Paulo, Sao Paulo, Brazil11-5020090
Lanx Capital InvestimentosSao Paulo, Sao Paulo, Brazil11-5020032
Beagle VenturesSantiago, Santiago, Chile1-1020160


Want to find more investors focusing on the bioinformatics industry?

If you want to find more investors that are active in the bioinformaticsindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!